Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › Ohio › Akron
Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Akron, OH keessatti
Qorannoo 22 Kansara Qara'a Non-Small Cell f Akron fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Namoota walitti qabaa jiraSadarkaa 3
- Cleveland Clinic Akron General, Akron
- Aultman Health Foundation, Canton · Miili 21 fagaatti
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Namoota walitti qabaa jiraSadarkaa 3
- Aultman Health Foundation, Canton · Miili 21 fagaatti
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Namoota walitti qabaa jiraSadarkaa 3
- Akron General Medical Center, Akron
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Canton · Miili 21 fagaatti
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Aultman North, North Canton · Miili 15 fagaatti
- Aultman Massillon, Massillon · Miili 20 fagaatti
- Aultman Orrville Hospital, Orrville · Miili 21 fagaatti
- fi 2 dabalataa
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Aultman Hospital, Canton · Miili 21 fagaatti
Pan-tumor MRD Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Gabrail Cancer Center, Canton · Miili 21 fagaatti
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Namoota walitti qabaa jiraSadarkaa 2/3
- Gabrail Cancer Center Research, Canton · Miili 21 fagaatti
A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
Namoota walitti qabaa jiraSadarkaa 2
- Gabrail Cancer Center, Canton · Miili 21 fagaatti
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Namoota walitti qabaa jiraSadarkaa 2/3
- Tricounty Hematology and Oncology - Massillon, Massillon · Miili 20 fagaatti
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
Namoota walitti qabaa jiraSadarkaa 1/2
- Gabrail Cancer Center Research, Canton · Miili 21 fagaatti
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Gabrail Cancer Center, Canton · Miili 21 fagaatti
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Gabrail Cancer and Research Center, Canton · Miili 21 fagaatti
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Cleveland Clinic Mercy Hospital, Canton · Miili 21 fagaatti
- Aultman Health Foundation, Canton · Miili 21 fagaatti
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Aultman Health Foundation, Canton · Miili 21 fagaatti
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2/3
- Aultman Health Foundation, Canton · Miili 21 fagaatti
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Aultman Health Foundation, Canton · Miili 21 fagaatti
GEMINI-NSCLC: NSCLC Biomarker Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Aultman Hospital, Canton · Miili 21 fagaatti
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Gabrail Cancer & Research Center, Canton · Miili 21 fagaatti
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Research Site 138, Canton · Miili 21 fagaatti
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Namoota walitti qabaa jiraSadarkaa 1/2
- Gabrail Cancer Center Research, Canton · Miili 21 fagaatti
FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
Namoota walitti qabaa jiraSadarkaa 1/2
- Gabrail Cancer Research Center, Canton · Miili 21 fagaatti
Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti
- Houston, TXQorannoo 145
- New York City, NYQorannoo 121
- Arlington, VAQorannoo 104
- Nashville, TNQorannoo 97
- Boston, MAQorannoo 90
- Los Angeles, CAQorannoo 87
- St. Louis, MOQorannoo 73
- Chicago, ILQorannoo 61
- Baltimore, MDQorannoo 60
- San Antonio, TXQorannoo 59
- Columbus, OHQorannoo 57
- Washington, DCQorannoo 55
Qorannoo biroo Akron keessatti
- Dhibee QaraQorannoo 16
- Saree OljooQorannoo 13
- Saree (Gosoota Hunda)Qorannoo 13
- Kansarii ProstateQorannoo 9
- Kansara MetastatikiiQorannoo 8
- Leukemia Myeloidii HamaaQorannoo 8
- Kansarii Hafuu Seli XiqqaaQorannoo 8
- MelanomaQorannoo 8
- Kansarii ColorectalQorannoo 8
- Dhukkubaa Harkaa SteatoticQorannoo 7
- SchizophreniaQorannoo 6
- StrokeQorannoo 6
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.